AQR's exit of nearly 80% of its position removes a significant institutional holder. Monitor for further institutional selling and whether other large holders (Perceptive Advisors, Vanguard) adjust their positions in upcoming filings.
ALDX drugs
ALDX drug pipeline →How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 12 $0.6301entry
- T+1 · 4d ago +2.17%α +2.54% · $0.6438
- T+3 · todayOpen
- T+5 · tomorrow Pending
- T+20 · in 24d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
AQR Capital Management LLC filed an amended Schedule 13G disclosing a reduced passive stake in Aldeyra Therapeutics, dropping from 5.48% (3,310,587 shares) as of September 30, 2026 to 1.11% (672,616 shares) as of the filing date. This significant reduction signals a major exit by a top institutional holder.
Key Financial Metrics
Key Facts
- AQR Capital Management reduced its stake in Aldeyra Therapeutics from 5.48% to 1.11% of shares outstanding.
- AQR now holds 672,616 shares, down from 3,310,587 shares as of September 30, 2026.
- The filing is an amendment to Schedule 13G, confirming AQR remains a passive investor.
- AQR was previously the largest institutional holder per the Q2 2026 13F snapshot.
Financial Impact
AQR sold approximately 2,637,971 shares, representing a 79.7% reduction in its position.
Risk Factors
- Loss of a major institutional holder may pressure the stock and reduce liquidity.
- Could signal waning confidence in Aldeyra's prospects ahead of potential catalysts.
- Remaining holders may follow suit, amplifying selling pressure.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001167557-26-000229 |
| Document: 0001167557-26-000229-index.html | 0001167557-26-000229 |
| Document: 0001167557-26-000229.txt | 0001167557-26-000229 |
Track record
12 reports on ALDX
2 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +59.67% at T+60 after the Aug 16, 2026 report. 3 of 5 went positive at some point.
Filters
- Nov 17, 2026today 8-K Bearish 7/10 Entry $0.6799 Now $0.6939 −2.06% settles Dec 17
- Nov 13, 20264d ago Insider Cluster Neutral 4/10 Entry $0.6696 Now $0.6939 +3.63% settles Dec 15
- Nov 12, 20265d ago SC 13G/A Bearish 5/10 Viewing Entry $0.6301 Now $0.6939 −10.13% settles Dec 11
- Nov 9, 20268d ago 8-K Bearish 6/10 Entry $0.6291 Now $0.6939 −10.30% settles Dec 9
- Nov 6, 202611d ago SC 13G Neutral 3/10 Entry $0.6337 Now $0.6939 +9.50% settles Dec 7
- Nov 4, 202613d ago Institutional Cluster Bearish 4/10 Entry $0.6474 Now $0.6939 −7.18% settles Dec 3
- Sep 29, 20267w ago 8-K Bullish 7/10 Entry $1.32 to $0.6412 Now $0.6939 −47.43% ▼ −51.42% −52.14% vs SPY
- Aug 16, 202613w ago Institutional Cluster Bearish 6/10 Entry $1.56 to $1.37 Now $0.6939 +55.52% ▲ +12.18% +10.20% vs SPY
- Jul 30, 202615w ago 8-K Neutral 2/10 Entry $1.54 to $1.49 Now $0.6939 −54.94% ▼ −3.57% −6.56% vs SPY
- Apr 27, 202629w ago DEFA14A Neutral 2/10 Entry $1.57 to $1.78 Now $0.6939 −55.80% ▲ +13.38% +7.91% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers